Introducing STAT’s Trust in Science Initiative [STAT Summit 2026 Review #23]

Report 23. Introducing STAT’s Trust in Science Initiative

Part I. English Version

1. Event / Date & Time

Event: Introducing STAT’s Trust in Science Initiative

Conference: STAT Summit 2026

Date & Time: October 15, 2026 | 10:35 AM EDT

2. Participants

Speakers

- Nicholas Florko — Trust-in-Science Reporter, STAT

- Rick Berke — Co-Founder and Executive Editor, STAT

3. Summary

Dedicated Science Reporting: STAT introduced a new reporting initiative to investigate the causes and consequences of declining public trust in science.

Journalism and Evidence: The program aims to move beyond individual controversies and identify systemic patterns affecting confidence in biomedical institutions.

Philanthropic Collaboration: Foundation support is being used to build specialized reporting and editorial capacity on science and public trust.

4. Main Discussion

Why a Trust-in-Science Beat?

Berke explained that discussions with journalism supporters prompted STAT to examine trust as a theme cutting across drug development, regulation, vaccines and public health. He said the newsroom concluded that trust deserved a dedicated reporting position rather than occasional coverage of individual disputes. The initiative introduced Nicholas Florko as its trust-in-science reporter.

Berke traced the initiative to discussions between newsroom leaders and philanthropic journalism supporters. Rather than treating vaccine disputes, FDA debates and institutional confidence as unrelated episodes, the participants recognized trust as a recurring question across STAT’s health, medicine and science coverage. A dedicated beat could support sustained reporting on why trust is earned, lost or unevenly distributed. He explained that the project created both a reporting position and an editorial role, allowing time for investigations instead of limiting coverage to breaking controversies. The initiative was presented as a new journalistic undertaking, not as a clinical research intervention or a program that had yet demonstrated an effect on public confidence.

STAT presented the initiative as a distinct editorial commitment rather than a one-off series on vaccine misinformation. Rick Berke explained that conversations with philanthropic supporters led the organization to see trust as a common thread across its reporting on drugs, FDA oversight, public health and new technology. The organization subsequently sought additional support to hire a dedicated reporter and editor. This structural choice matters because coverage can examine causes of mistrust over time, rather than responding only when controversy becomes prominent. It also raises questions about editorial independence and the need to remain open about how public-interest journalism is funded, even when supporters share an interest in a topic.

Funding and Editorial Capacity

The discussion identified support from several philanthropic institutions, including the Dana Foundation, John Templeton Foundation and Boston Foundation. The funding supports a reporter and an editor dedicated to the initiative. Berke emphasized that scientific trust was a substantial enough subject to warrant a durable editorial investment.

The discussion described support from foundations including the Dana Foundation, John Templeton Foundation and Boston Foundation. Berke also referred to earlier conversations with journalism backers as the concept evolved. Nicholas Florko had previously covered STAT for six years, spent two years at The Atlantic, and returned to take the new assignment. The editors presented the appointment as an investment in subject-matter expertise that can question institutions while also helping readers understand science. Their explanation did not establish a numerical target for articles or an independent metric of success. Instead, the emphasis was on maintaining the capacity to investigate issues that cut across regulation, health policy, public expectations and technologies over time.

Nicholas Florko described the purpose of the new beat as investigating why confidence in science has eroded, who has been excluded from credible conversations and which institutional actions either strengthen or weaken trust. His prior reporting on the FDA and health policy informed this approach. The initiative therefore framed distrust as a legitimate subject of investigation rather than merely an obstacle that scientists need to overcome with better public relations. Important questions include whether institutions behave consistently with their own standards, how errors are disclosed and how communities experience expert authority. These issues have direct implications for the adoption of new medicines and technologies even though the session was about journalism, not an experimental research study.

Investigating Systemic Causes of Distrust

Florko emphasized that the objective is not to chase every viral social-media incident but to select stories revealing broader patterns in trust and mistrust. Drawing on prior coverage of FDA policy and public health, he described the challenge of explaining why institutional confidence declines and challenging readers’ assumptions with evidence.

Florko emphasized that the work cannot simply begin with the assumption that disagreement proves scientific illiteracy. The newsroom wants to examine how systems of regulation, clinical research, professional communication and political debate affect what different publics believe. That requires selecting stories with an explanatory payoff rather than treating each inflammatory statement as equally representative. The panel’s discussion linked investigative journalism to the transparency of scientific institutions, since credible reporting can scrutinize both evidence and the procedures through which experts reach conclusions. For biomedical companies and research organizations, the practical message was that public trust is influenced by the quality of decisions and the accessibility of explanations, not just by how positively an innovation is promoted.

The presenters mentioned support from philanthropic organizations including the Greenwall Foundation, Dana Foundation, John Templeton Foundation and Boston Foundation. Funding for a dedicated position makes continuing coverage feasible, but it does not itself demonstrate that trust will increase. The value of the initiative will depend on the quality, rigor and responsiveness of its reporting as well as whether it represents groups whose concerns are usually missing from elite science discussions. For R&D leaders, the practical lesson is to expect questions about evidence, incentives and governance—not only the effectiveness of a technology—and to prepare substantive, checkable answers.

Florko used the immediately preceding vaccine-hesitancy panel as an example of the type of assumptions the new beat intends to question. He reflected on Jennifer Reich’s argument that parents are repeatedly told to research choices and become experts on their own children, then criticized when they attempt to exercise similar judgment on vaccination. He distinguished understanding why a belief is attractive from endorsing a scientifically unsupported conclusion. That distinction illustrates a reporting method: investigate incentives, expectations and lived experiences that shape trust without abandoning accurate descriptions of scientific evidence.

The launch announcement also showed how editorial capacity affects the depth of a public-interest subject. Florko had previously spent six years reporting for STAT and two years at The Atlantic before returning to lead this beat. A dedicated assignment allows him to move across regulatory institutions, healthcare technology, public attitudes and scientific practice rather than treating trust as a narrow communications specialty. The session did not outline a fixed set of measurable outcomes for the initiative, so its success will have to be assessed through the usefulness and rigor of future reporting, not simply the announcement of the role.

The presenters recognized that distrust is a difficult issue for journalism precisely because it crosses traditional editorial beats. A disputed vaccine recommendation can involve sociology, medicine, policy and politics at once; a controversy over an AI tool may involve similar questions about evidence and institutional accountability. A specialist reporter can follow these connections and ask researchers not only what the evidence says, but also how institutions respond when their judgments are challenged. The initiative thus adds an investigative function to STAT’s existing coverage instead of treating trust as a separate public-relations topic. Whether this approach changes audience understanding remains to be established.

5. Insights

Evidence-Based Communication: Investigative science journalism can reveal gaps between scientific evidence, institutional behavior and public perceptions.

Implications for South Korea: Korea could consider sustained, specialized communication and independent scrutiny around scientific policy rather than campaign-based messaging alone.

Information Ecosystems: Collaboration among researchers, journalists and civic institutions may support informed public debate while preserving editorial independence.

Report 23. Introducing STAT’s Trust in Science Initiative_eng.pdf

Download PDF • 71KB